Evidence map›Paper›PMID 38124086›Full record

ArticleBMC medical informatics and decision making2023

Particle filter-based parameter estimation algorithm for prognostic risk assessment of progression in non-small cell lung cancer.

Shi Shang, Junyi Yuan, Changqing Pan, Sufen Wang, Xuemin Tu, Xingxing Cen, Linhui Mi, Xumin Hou

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shi ShangInformation Center, Shanghai Chest Hospital , School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Junyi YuanInformation Center, Shanghai Chest Hospital , School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Changqing PanHospital's Office, Shanghai Chest Hospital , School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Sufen WangGlorious Sun School of Business and Management, Donghua University, Shanghai, China.
Xuemin TuDepartment of Mathematics, University of Kansas, Lawrence, KS, USA.
Xingxing CenInformation Center, Shanghai Chest Hospital , School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Linhui Mi *Information Center, Shanghai Chest Hospital , School of Medicine, Shanghai Jiao Tong University, Shanghai, China. mlh0428@163.com.
Xumin Hou *Hospital's Office, Shanghai Chest Hospital , School of Medicine, Shanghai Jiao Tong University, Shanghai, China. houxumin@shchest.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-small cell lung cancer (NSCLC) is a malignant tumor that threatens human life and health. The development of a new NSCLC risk assessment model based on electronic medical records has great potential for reducing the risk of cancer recurrence. In this process, machine learning is a powerful method for automatically extracting risk factors and indicating impact weights for NSCLC deaths. However, when the number of samples reaches a certain value, it is difficult for machine learning to improve the prediction accuracy, and it is also challenging to use the characteristic data of subsequent patients effectively. Therefore, this study aimed to build a postoperative survival risk assessment model for patients with NSCLC that updates the model parameters and improves model accuracy based on new patient data. The model perspective was a combination of particle filtering and parameter estimation. To demonstrate the feasibility and further evaluate the performance of our approach, we performed an empirical analysis experiment. The study showed that our method achieved an overall accuracy of 92% and a recall of 71% for deceased patients. Compared with traditional machine learning models, the accuracy of the model estimated by particle filter parameters has been improved by 2%, and the recall rate for dead patients has been improved by 11%. Additionally, this study outcome shows that this method can better utilize subsequent patients' characteristic data, be more relevant to different patients, and help achieve precision medicine.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsAlgorithmsHumansPrognosisRisk AssessmentNSCLCParameter estimationParticle filteringRisk assessment model

Identifiers

PMID38124086
PMCPMC10731873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.